149 related articles for article (PubMed ID: 8658079)
1. Increased bactericidal activity as documented by serum bactericidal titers for a triple combination of cell wall active agents against gentamicin-resistant enterococci.
Antony SJ; Matherin P; Stratton C
Scand J Infect Dis; 1995; 27(4):401-3. PubMed ID: 8658079
[TBL] [Abstract][Full Text] [Related]
2. Aminoglycoside resistant enterococcal endocarditis.
Eliopoulos GM
Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
[TBL] [Abstract][Full Text] [Related]
3. Gentamicin-resistant Enterococcus faecalis sequence type 6 with reduced penicillin susceptibility: diagnostic and therapeutic implications.
Guardabassi L; Larsen J; Skov R; Schønheyder HC
J Clin Microbiol; 2010 Oct; 48(10):3820-1. PubMed ID: 20702669
[No Abstract] [Full Text] [Related]
4. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
[TBL] [Abstract][Full Text] [Related]
5. High-level aminoglycoside-resistant enterococcus causing endocarditis successfully treated with a combination of ampicillin, imipenem and vancomycin.
Antony SJ; Ladner J; Stratton CW; Raudales F; Dummer SJ
Scand J Infect Dis; 1997; 29(6):628-30. PubMed ID: 9571747
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
Messick CR; Woodward J; Pendland SL
Diagn Microbiol Infect Dis; 1998 Oct; 32(2):95-9. PubMed ID: 9823531
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM
Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374
[TBL] [Abstract][Full Text] [Related]
8. Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium.
Caron F; Carbon C; Gutmann L
J Infect Dis; 1991 Nov; 164(5):888-93. PubMed ID: 1940467
[TBL] [Abstract][Full Text] [Related]
9. Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.
Aamodt H; Mohn SC; Maselle S; Manji KP; Willems R; Jureen R; Langeland N; Blomberg B
BMC Infect Dis; 2015 Feb; 15():107. PubMed ID: 25884316
[TBL] [Abstract][Full Text] [Related]
10. Influence of adjunctive interferon-gamma on treatment of gentamicin- and vancomycin-resistant Enterococcus faecalis infection in mice.
Onyeji CO; Bui KQ; Nicolau DP; Nightingale CH; Bow L; Quintiliani R
Int J Antimicrob Agents; 1999 Aug; 12(4):301-9. PubMed ID: 10493606
[TBL] [Abstract][Full Text] [Related]
11. A case of vancomycin-resistant enterococcal endocarditis.
Brink AJ; van den Ende J; Routier RJ; Devenish L
S Afr Med J; 2000 Nov; 90(11):1113-5. PubMed ID: 11196031
[No Abstract] [Full Text] [Related]
12. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal activity and killing rate of serum against gram-positive cocci in volunteers receiving imipenem, oxacillin, vancomycin or ampicillin plus gentamicin.
Van der Auwera P; Van Laethem Y; Klastersky J
J Antimicrob Chemother; 1987 Aug; 20(2):239-49. PubMed ID: 3478329
[TBL] [Abstract][Full Text] [Related]
14. [Enterococcal endocarditis, a model of therapeutic difficulty].
Fernández Guerrero ML; Núñez García A
Rev Clin Esp; 1995 Oct; 195 Suppl 4():41-5. PubMed ID: 9441316
[No Abstract] [Full Text] [Related]
15. The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci.
Itokazu GS; Nathan C; Hariharan R; Kostman JR; Kabins SA; Weinstein RA
Chemotherapy; 1996; 42(4):235-9. PubMed ID: 8804789
[TBL] [Abstract][Full Text] [Related]
16. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M
Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium.
Mekonen ET; Noskin GA; Hacek DM; Peterson LR
Microb Drug Resist; 1995; 1(3):249-53. PubMed ID: 9158783
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci.
Kariyama R; Kumon H; Chow L; Zervos MJ; Takata T; Tabata M; Chow JW
J Antimicrob Chemother; 1998 Dec; 42(6):836-8. PubMed ID: 10052913
[No Abstract] [Full Text] [Related]
19. Rapid increase in the prevalence of antimicrobial drug resistance among enterococcal blood isolates in southern Israel.
Marcus N; Peled N; Yagupsky P
Eur J Clin Microbiol Infect Dis; 1997 Dec; 16(12):913-5. PubMed ID: 9495672
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium.
Caron F; Pestel M; Kitzis MD; Lemeland JF; Humbert G; Gutmann L
J Infect Dis; 1995 Jan; 171(1):106-12. PubMed ID: 7798650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
